Practical Patient Care Weekly
Practical Patient Care
Your one stop, leading multi-platform news source for the global healthcare sector.
Welcome to another edition of the Practical Patient Care newsletter!
Discover the latest insights and analyses from the global healthcare market over the past week, brought to you by Practical Patient Care
Intelliguard? has launched its innovative Mira Ecosystem
Intelliguard? has launched its innovative Mira Ecosystem, a comprehensive suite of medication management and data intelligence solutions designed to enhance safety and operational efficiency in healthcare settings.
This new product line aims to revolutionize medication and inventory management through advanced technologies and integrated workflows.
Bosch Healthcare Solutions GmbH has just launched a ground-breaking PCR rapid test for Vivalytic
Capable of detecting three major gastroenteritis pathogens: C. difficile, norovirus, and rotavirus.
This innovative test is the world's first fully automated PCR test for these pathogens at the point of care.
Marc Meier, president of Bosch Healthcare Solutions, emphasizes the test's impact: "We developed this test so that medical practices and clinics can identify the cause of gastroenteritis more quickly and respond appropriately: with the right treatment and measures to prevent further spread and infection."
The Vivalytic analyzer delivers results in under an hour, right on-site, revolutionizing gastroenteritis diagnosis.
This advancement is crucial for rapid treatment initiation and infection control, especially for C. difficile cases where quick sample processing is vital.
Senderra Specialty Pharmacy has launched SenderraCare+, an innovative digital solution aimed at revolutionizing the management of specialty medications.
They have launched SenderraCare+, a ground-breaking digital solution designed to transform the management of specialty medications.
This innovative platform enhances patient experience by providing accessibility across devices, real-time updates on medication status, and two-way communication with healthcare providers.
Patients can easily enroll via SMS, manage prescriptions digitally, and improve adherence to their medications. SenderraCare+ simplifies processes for both patients and providers, ensuring better healthcare outcomes.
领英推荐
赛默飞世尔科技 has partnered with the National Cancer Institute (NCI) (NCI) for the ground-breaking myeloMATCH precision medicine trial.
This collaboration aims to revolutionize treatment for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
Using Thermo Fisher Scientific's cutting-edge Ion Torrent Genexus System, researchers can now perform rapid genomic testing on patients' bone marrow and blood samples. This next-generation sequencing technology allows for quick identification of specific genetic biomarkers, enabling faster patient matching with appropriate clinical trials.
The goal? To deliver comprehensive genomic results within days, dramatically speeding up patient enrolment in targeted sub-studies.
This approach not only accelerates research but also increases access to precision oncology treatments for those battling these aggressive cancers.
Our representative Glen Savage eagerly anticipates reconnecting with industry colleagues and forging new partnerships. Visit booth #4521 to explore tailored marketing campaigns guaranteed to drive growth, amplify global reach, and generate qualified leads.
Book a meeting with Glen to discuss cutting-edge strategies for navigating the evolving healthcare landscape.
Additionally, Practical Patient Care is unveiling its Diagnostic Special 2024 journal, offering targeted exposure, credible brand visibility, and multi-channel reach to over 65,000 clinical professionals.
Don't miss your opportunity to maximise your impact at this years ADLM 2024.
To have a story featured on next week's newsletter, or require press and marketing support you can contact our team directly...
Editorial Enquiries - [email protected]
Press & Marketing support - [email protected]
Thanks for reading; we hope you enjoyed it.
Until next week.